chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea,; Diziness; Vertigo; Fatigue; chills; This spontaneous case was reported by a physician and describes the occurrence of NAUSEA (Nausea,), DIZZINESS (Diziness), VERTIGO (Vertigo), FATIGUE (Fatigue) and CHILLS (chills) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 27-Feb-2021, the patient experienced FATIGUE (Fatigue) and CHILLS (chills). On 28-Feb-2021, the patient experienced NAUSEA (Nausea,), DIZZINESS (Diziness) and VERTIGO (Vertigo). On 27-Feb-2021, FATIGUE (Fatigue) and CHILLS (chills) had resolved. On 28-Feb-2021, NAUSEA (Nausea,), DIZZINESS (Diziness) and VERTIGO (Vertigo) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Lab data: Blood pressure 160/78 (normal) and Heart rate 52  Concomitant product: Medicine for cholesterol  Treatment product was not consumed   Reporter did not allow further contact
This is a spontaneous report from a contactable consumer, the patient. This 65-year-old non-pregnant female patient reported that she received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9809) via an unspecified route in the left arm on 15Feb2021 at 10:15 (at the age of 65-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. The patient had no known allergies. There were no concomitant medications. The patient did not have COVID-19 prior to vaccination. The patient had not received any other vaccines within 4 weeks of the vaccination. The patient previously received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9262) on 23Jan2021 at 19:30 (at the age of 65-years-old) in the left arm as a single dose for COVID-19 immunization. On 15Feb2021 at 21:00, patient experienced diarrhea for 7 days, white coated tongue followed by tongue swelling (3 instances) occurring about every 2 weeks for 6 weeks following vaccine, throat tightness, heart - PVC's. The events resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the events which included fexofenadine hcl (ALLEGRA) four times a day; epinephrine (EPI-PEN). The outcome of the events was unknown. The patient was COVID tested post vaccination via nasal swab on 14Apr2021 with result: negative. Follow-up attempts are completed. No further information is expected.
COVID 19 Treatment; COVID 19 Treatment; vaccine brand other=Moderna; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Sep2022 at 10:00 as dose 5 (booster), single (Lot number: Gh9694) at the age of 70 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 16May2022 as dose 4 (booster), single (Lot number: 056m21a), in left arm for covid-19 immunisation; COVID-19 VACCINE (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 27Sep2022, outcome "unknown", described as "vaccine brand other=Moderna"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19: the patient received Paxlovid from 03Aug2023 to 07Aug2023.
The morning after my 2nd shot I experienced extreme pain, weakness and limited mobility in both my arms. This has continued despite 12 weeks of physical therapy, acupuncture, massage therapy, and chiropractic. I finally had some blood work done that showed elevated inflammatory markers and was prescribed a NSAID to see if it helped pain and inflammation. I had an allergic reaction to NSAID, which is new- I have never experienced allergies from these types of meds. I was instructed to stop NSAID and begin a course of steroid, which has given me relief. We will determine if these are long term results or if the inflammation is chronic after the course of steroids are completed.
Client came to Health Department with complaints about possible reaction to flu vaccine. States developed itching and burning of eyes on 10/03, Visine helped.  Hx of problems with itching of eyes in the past "from pollen."  The itching and burning lasted one day.  On 10/05/2010 developed fever, did not take temperature, "not real hot".  Ibuprofen brings the temperature down.  States he has a fever every day.  He has taken ibuprofen on and off for years for gout and arthritis.  He developed bleeding gums on 10/10/2010.  He also developed left arm pain on 10/10/2010, takes Tylenol #3 for that, which helps.  History of SOB x 1 year, not any worse now.  Hx HTN, states BP has been elevated off and on for the past 1 1/2 weeks, 160/80 today.  He takes Norvasc and Allupurinol 300 mg every am.  Recent change of gout med, doesn't know why.  He stopped taking a diuretic on his own about 1 year ago.  In our clinic on 10/11/2010, he appears flushed and a little sweaty.  I did not take his temperature.  Instructed to see private provider about these issues.  Phone call to client to see how he was doing, phone "disconnected".  Will send letter to request client to call Health Department to see how he is doing, and if he saw private provider.
Nausea then headache at 5:00 pm. Progressively worse all night unable to sleep with bossy aches chills and fever all the next day. It almost 9:00 hopefully this stops tomorrow
Information has been received from a nurse concerning a 20 year old female patient with no medical history or known drug reactions who was vaccinated (date unknown) with a first dose of GARDASIL (lot # not provided).  There was no concomitant medication.  The patient was reported as HPV positive (PAP smear found cell abnormality).  The patient contacted the physician for unknown medical attention.  The patient has not recovered.  There was no product quality complaint involved.  Additional information has been requested.
when I laid down I had dizziness. The dizziness was more intense when I was lying; low grade fever; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS POSTURAL (when I laid down I had dizziness. The dizziness was more intense when I was lying) and PYREXIA (low grade fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 025A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced DIZZINESS POSTURAL (when I laid down I had dizziness. The dizziness was more intense when I was lying) and PYREXIA (low grade fever). At the time of the report, DIZZINESS POSTURAL (when I laid down I had dizziness. The dizziness was more intense when I was lying) and PYREXIA (low grade fever) had resolved.            No concomitant medications were reported.   No treatment information was provided.   This case was linked to MOD-2021-075203 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up was received Patient demographics were added email address were added
This spontaneous report as received from a physician via company representative refers to a female patient of unknown age. Patient's medical history and concurrent conditions were not provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (route, lot # and expiration date were not provided). On an unknown date, the patient was vaccinated with the second dose of GARDASIL (route, lot # and expiration date were not provided). Concomitant therapies information was not provided. The physician mentioned that on an unknown date, the patient developed eye pain, described as ocular pain, after receiving the second dose of GARDASIL. It was stated that the ocular pain began hours after the patient received GARDASIL. The patient sought medical attention through an office visit. On an unknown date, the patient recovered from ocular pain. Additional information has been requested.
Redness @ injection site, pain in axilla area severe. injection site warm to touch, feeling achy, fatigued.
general moderate joint pain, chills, moderate headache, fatigue  mostly gone by the morning of 3/5/2021
have shingles, have shingles shot/Suspected vaccination failure; shingles; This case was reported by a consumer via (Shingrix GSK Chatbot) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The reporter think he/she had shingles, and had the shingles shot. The reporter also asked how often he/she need the shot. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation were unknown at the time of reporting. No contact details were available.
Within a few hours post vaccination I became very nauseous and had abdominal cramping.  Also just a general feeling of being unwell.  11/13/2009 7AM still experiencing nausea and cramping and then diarrhea.  By late afternoon, 4 PM 11/13/2009, feeling very tired, nauseous, headache, body ache, sore throat, beginning to get upper respitory congestion.  11/14/2009 symptoms worsened.  Very sore throat.  Cough developed.  Approximately 4 PM 11/14/2009 developed a low grade fever and chills.  These passed within a few hours after taking a low dose of Tylenol.  11/15/2009 feeling somewhat better.  Congestion decreased, no sore throat, some muscle ache and fatigue.  Same for 11/16/2009.  Cough increased on 11/16/2009 and became progressively worse throughout the day.  By 6 PM 11/16/2009 headaches, aggrivating/non productive cough, sore throat and laryngitis.  11/17/2009 7:30 AM laryngitis, mild headache, muscle ache and deeper chest cough.
103 temp (started 3/31 lasted a day), violent chills, (started on 30th for 3+ hours) enlarged lymph nodes (started 4/1 and continuing), body aches (since 3/31 continuing), nauseau (started 3.30 continuing) fatigue (started 3.30 continuing), headache, (started 3/30 continuing) horrible rash on legs, feet, arms (not just where the vaccine was given)started 4/2 and getting worse
2/5/21- Received 2nd dose of COVID-19 vaccine 2/8/21- elbows and arms began to itch in the afternoon. By the evening, legs and back were itchy too. 2/9/21- body from the neck down was itchy and covered in a red rash. Visited care clinic and received a prescription for Triamcinolone Acetonide Ointment 0.025% 2/10/21- woke up with swollen face and lips. swelling subsided within an hour of waking. Whole body still covered in rash and very itchy. was unable to complete a full day of work due to discomfort.  2/11/21- still covered in a full body rash and itchy with minor improvement.
Chills, fever 99.7-100.5, chills, headache, aches.
Large area on right thigh swollen and warm, red but not tender, it is itching.
Patient states she had rash on legs and hives spread over body. This resolved after one day. Patient still has rash near site of injection after 6 days. She states it still itches, but has improved in appearance.
Information has been received from a registered nurse, who is a public health nurse, concerning a nine year old male patient who on 08/05/1996 was vaccinated with varicella virus vaccine live.  During the first week of January 2005, the patient developed a chickenpox breakthrough.  There was no product quality complaint reported.  Unspecified medical attention was sought.  Additional information has been requested.
Hives (urticaria) appearing intermittently around feet, legs, hands, and trunk over the course of 5 days.
Child woke up with a severe bloody nose the night that his shot was received.  No history of nose bleeds.
I started having a reaction on September 22, 2022 I experienced a rash on my thigh that spread from one thigh to the other and also up my arm and a little on my chest. When I went to the Dr. I was prescribed prednisone and it did not help then after I went to my primary Dr. and I was prescribed fluocinonide after taking it. I still did not have any relief I went back to my Dermatologist and she suspected that it may be shingles and I was prescribed a pill valacyclovir HCL 1G tablet 3 times a day and I was prescribed an ointment to be used twice a day called fluocinonide .05. BENADRYL in evening and ZYRTEC in the mornings.
This spontaneous report was received from a healthcare professional via social media refers to female patients of unknown age. The patients medical history, concurrent condition and concomitant medications were not reported. On an unknown date, the patients were vaccinated with GARDASIL for prophylaxis (strength, dose, frequency, route, lot#  and expiry were not reported). On an unknown date, 7 out of the 8 women died in protocol GARDASIL (death), some experienced cough, erythema, swelling and pain. The cause of death was not reported and it was unknown if autopsy was performed. Outcome of pain, cough, erythema and swelling was unknown. Causality assessment of the events was not reported.
(R) deltoid red, warm, and discomfort voiced per patient. No treatment needed at this time. - Suspected reaction.
No adverse event, but vaccination was administered outside authorized age range.  Parents reported to nursing home staff when signing child up that he was 12 years of age.  Age discrepancy was noticed when entering the vaccination into the VAMS system.  Parents were called and they acknowledged that he was only 11 years of age and they knew the recommendations for the vaccination were for children 12 years of age and older.
Information has been received from a physician concerning his 55 year old wife with no known drug allergies and a history of cold sores who on 07-MAR-2008 or 08-MAR-2008 was vaccinated SQ with one dose of 0.65mL of zoster vaccine live (Oka/Merck). Concomitant therapy included hormone replacement therapy (unspecified manufacturer/brand). Subsequently, on 11-MAR-2008 the patient experienced an outbreak of herpes simplex virus (HSV-1). The physician does not think the vaccine is related to her symptoms. Medical attention was sought, the physician was called. There were no lab studies performed. At the time of the report the patient was not recovered. There was no product quality complaint involved. Additional information has been requested.
Broke out with a rash.  Started Friday on arms, chest.  Sat now spread to her neck, thighs.  Sat 11/01, called clinic for appointment, schedule at 11/02/2003 @ 13:00.  Told to use Benadryl and Oatmeal bath.  MD appointment received Hydroxygen-PC 25mg Tab/Medrol Dose Pack 4mg.
hospitalized. Bilateral lower extremity weakness. Already improved overnight. PT eval.  Symptom onset 04/09. Non-hypoxic. Apart from obesity and hypertension, no significant risk for disease progression.
my blood sugars have steadily increased as has my HgbA1C / after receiving the booster there was a significant steady increase in my blood sugars; This spontaneous case was reported by a nurse and describes the occurrence of HYPERGLYCAEMIA (my blood sugars have steadily increased as has my HgbA1C / after receiving the booster there was a significant steady increase in my blood sugars) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Since the last two years, the patient was free from Covid-19 infection, even after working in the emergency room and treating dozens of infected patients during that time.  Concurrent medical conditions included Insulin-requiring type 2 diabetes mellitus (patient is a type 2 insulin dependent diabetic since age 30) and Exercise regular (patient went to the gym 2-3 days in a week to do 1-2 hours of exercise). Concomitant products included METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) and INSULIN ASPART (NOVOLOG) for an unknown indication.    In November 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2022, the patient experienced HYPERGLYCAEMIA (my blood sugars have steadily increased as has my HgbA1C / after receiving the booster there was a significant steady increase in my blood sugars). At the time of the report, HYPERGLYCAEMIA (my blood sugars have steadily increased as has my HgbA1C / after receiving the booster there was a significant steady increase in my blood sugars) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: Since receiving the bivalent Moderna Covid vaccine in November, blood sugars had steadily increased as well as her HgbA1C.. On an unknown date, Glycosylated haemoglobin: Since receiving the bivalent Moderna Covid vaccine in November, blood sugars had steadily increased as well as her HgbA1C..     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   The patient took Novolog via insulin pump. The patient worked closely with the endocrinologist.  It was reported that within 10 days to 2 weeks after receiving the booster dose of the vaccine, there was a significant steady increase in both fasting and postprandial blood sugar levels of the patient without any change in diet/exercise. The patient went to the gym 2-3 days in a week to do 1-2 hours of exercise and muscle toning which had not changed.  The patient wanted to make this known to see if this was just happening due to the patient's bad luck, or if this was a recurring issue with other diabetic patients as well after Moderna vaccination.  The patient wanted to know that for how long should the patient expect this anomaly and, or what to do about it beside increasing the injectable insulin dose.  The patient was treated with injectable insulin dose.
pt recvd vax & it was unclear whether the pt became hiv pos after or before vax; lab evaluation showed hepatitis b surface antigen pos & core antibody pos;
Had a massive headache for 2 days, then a rash for the past 3 days on injection rate that felt hot to touch and soreness.   Rash has slowly gone away.
This spontaneous report was received from Pfizer Inc and was assigned manufacturer report number (2017048505) for PREVNAR 13. This was originally reported by a currently 70-year-old female patient with sleeping disorder, who refers to herself. The patient's medical history were not reported. In January 2015, the patient was vaccinated with one dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (dose, route of administration, lot number, expiration date were not reported) for prophylaxis, per physician's recommendation. Concomitant medication included zolpidem. No longer than five weeks after receiving pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown), the blood test was done to see if her resistance to pneumonia went up. The doctor explained to her that in his entire career he had never seen this, the patient entire chart was exactly the same after the vaccination. She finally got that she was not protected from pneumonia by vaccine (Vaccination failure). Her titer was less than 3 (unit not provided), low (nothing, non existent protection) (Antibody test negative). She should have had more protection, but did not find anything after she had a titer. It was also reported that the titer was less than 4 (unit not provided). The dose of vaccine was watered down (Product quality issue) and did not work (Vaccination failure). The outcome of the events was not reported. The relatedness between the events and pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) was not reported. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA009794.
cut in the finger and had to go to ER/cut his finger at work; He could not get bleeding to stop/ cutting his finger at work; This is a spontaneous report from a contactable other healthcare professional (also the mother of the patient) from a Pfizer-sponsored program.   A 22-years-old male patient (reported as weight: 140-145pounds) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Deltoid Left (reported as around between 11 or 12) on 10May2021 (Batch/Lot number was not reported) as 2ND DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took the first dose of bnt162b2 (Pfizer Covid 19 vaccine) on 18Apr2021 (Sunday) for COVID-19 immunization. It was reported that the patient had the second dose on 10May2021 (Monday) of the covid 19 vaccine had to go to ER and was hospitalized due to cutting his finger at work on 12May2021. The patient took a tetanus shot last night and she wants assurance that he should not be receiving other vaccines after the second dose. She is also concerned and asking if the tetanus will interfere with the efficacy of the vaccine. It was clarified that the patient was not admitted to the hospital, he went to emergency room late last night into the early morning. Confirms he went to ER on 12May2021.She thinks it was probably administered in his left deltoid because he is right handed. He is a healthy young man. For the treatment tetanus shot and gauze bandage with anticoagulant in it since he could not get stitched. He could not get bleeding to stop and then went to ER. Not life threatening. The events resulted in emergency room visit. The events were considered medically significant by the reporter. The outcome of the events was unknown.   Information on the lot/batch number has been requested.